✉ Email this page to a colleague
« Back to Dashboard
fluoruracil is an investigational drug.
There have been 29 clinical trials for fluoruracil. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2008.
The most common disease conditions in clinical trials are Breast Neoplasms, Colorectal Neoplasms, and Stomach Neoplasms. The leading clinical trial sponsors are University Hospital of Crete, Hellenic Oncology Research Group, and Gruppo Oncologico del Nord-Ovest.
Recent Clinical Trials for fluoruracil
|Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma||Kuwait Cancer Control Center||Phase 3|
|5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.||Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||Phase 1|
|Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients||Gruppo Oncologico Italiano di Ricerca Clinica||Phase 2|